Literature DB >> 30372911

MicroRNAs as biological regulators in skin disorders.

Gautam Singhvi1, Prachi Manchanda2, Vamshi Krishna Rapalli2, Sunil Kumar Dubey2, Gaurav Gupta3, Kamal Dua4.   

Abstract

microRNAs are being investigated as promising therapeutic targets and biomarkers for different disease conditions. miRNAs serve as essential regulators of cell differentiation, proliferation and survival. The involvement of miRNAs in the functioning and regulation of the skin cells and skin diseases is a rapidly advancing area in dermatological research. miRNAs have been identified to play a key role in the pathogenesis, diagnosis, and treatment of the skin diseases. Skin is one of the largest organs of the body, primarily functioning as the first line of defence against external insults including bacteria, virus and other pathogens. Various miRNAs have been identified to demonstrate significant effects in various skin inflammatory conditions such as wounds, cancer, psoriasis, scleroderma, dermatomyositis. The current review explores the possible roles of the miRNAs in skin disorders and reports relating to the clinical trials involving skin diseases and miRNAs. The review has also compiled the information of the databases available, which correlates the miRNAs with different diseases and give details about targeting interactions of miRNA.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Dermatomyositis; Psoriasis; Skin disorders; Wound healing; microRNAs; scleroderma

Mesh:

Substances:

Year:  2018        PMID: 30372911     DOI: 10.1016/j.biopha.2018.09.090

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  16 in total

Review 1.  Targeting microRNA for improved skin health.

Authors:  Xi Li; Sakthi Ponandai-Srinivasan; Kutty Selva Nandakumar; Susanne Fabre; Ning Xu Landén; Alain Mavon; Ia Khmaladze
Journal:  Health Sci Rep       Date:  2021-10-12

2.  Network analysis reveals dysregulated functional patterns in type II diabetic skin.

Authors:  Chunan Liu; Sudha Ram; Bonnie L Hurwitz
Journal:  Sci Rep       Date:  2022-04-27       Impact factor: 4.996

3.  Serum Levels of miR-146a in Patients with Psoriasis.

Authors:  Bárbara Leal; Cláudia Carvalho; Ana Marta Ferreira; Miguel Nogueira; Sandra Brás; Berta M Silva; Manuela Selores; Paulo P Costa; Tiago Torres
Journal:  Mol Diagn Ther       Date:  2021-05-02       Impact factor: 4.074

Review 4.  Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.

Authors:  Kinga Fanni Tóth; Dorottya Ádám; Tamás Bíró; Attila Oláh
Journal:  Molecules       Date:  2019-03-06       Impact factor: 4.927

Review 5.  MicroRNA in localized scleroderma: a review of literature.

Authors:  Katarzyna Wolska-Gawron; Joanna Bartosińska; Dorota Krasowska
Journal:  Arch Dermatol Res       Date:  2019-10-21       Impact factor: 3.017

6.  MicroRNA And Circular RNA Expression In Affected Skin Of Patients With Postherpetic Neuralgia.

Authors:  Song Cao; Dexin Zhang; Jie Yuan; Chengxi Liu; Wenjing Zhou; Lin Zhang; Shouyang Yu; Bangyong Qin; Ying Li; Wenwen Deng
Journal:  J Pain Res       Date:  2019-10-16       Impact factor: 3.133

7.  Pharmacoepigenomics circuits induced by a novel retinoid-polyamine conjugate in human immortalized keratinocytes.

Authors:  Katerina Grafanaki; Ilias Skeparnias; Christos K Kontos; Dimitrios Anastasakis; Aigli Korfiati; George Kyriakopoulos; Konstantinos Theofilatos; Seferina Mavroudi; George Magoulas; Dionissios Papaioannou; Andreas Scorilas; Constantinos Stathopoulos; Denis Drainas
Journal:  Pharmacogenomics J       Date:  2021-06-18       Impact factor: 3.550

Review 8.  The Role of MicroRNAs in Epidermal Barrier.

Authors:  Ai-Young Lee
Journal:  Int J Mol Sci       Date:  2020-08-12       Impact factor: 5.923

9.  Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers.

Authors:  Katarzyna Wolska-Gawron; Joanna Bartosińska; Marta Rusek; Małgorzata Kowal; Dorota Raczkiewicz; Dorota Krasowska
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

10.  MicroRNA-34a deficiency leads to impaired wound closure by augmented inflammation in mice.

Authors:  Na Zhao; Guojian Wang; Shuang Long; Mengjia Hu; Jining Gao; Xinze Ran; Junping Wang; Yongping Su; Tao Wang
Journal:  Ann Transl Med       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.